Hanson Kristopher
General Counsel
- Shares
- 16,509
- Price
- $11.67
- Value
- $192,660
MPLT
1 buyer account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
+$95,930,586
1 buyers · 2 sellers
12-month purchases
$99,557,496
4 distinct insiders
12-month sales
$17,476,863
8 distinct insiders
Highlighted alerts
13
73 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
MPLT overview: breakout setup, X sentiment and insiders in one page →
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.
Reason: tax_withholding. The filing footnotes identify tax withholding.
Voluntary purchases and sales; administrative noise stays hidden.
Hanson Kristopher
General Counsel
Catalyst4, Inc.
10% owner
Catalyst4, Inc.
10% owner
Lillie James Woodruff
Chief Scientific Officer
Catalyst4, Inc.
10% owner
Catalyst4, Inc.
10% owner
Catalyst4, Inc.
10% owner
Catalyst4, Inc.
10% owner
Cox Troy
Director
Kreitzer Anatol
Chief Discovery Officer
Kreitzer Anatol
Chief Discovery Officer
Kreitzer Anatol
Chief Discovery Officer
GILLIS JONATHAN
CAO and Interim CFO
GILLIS JONATHAN
CAO and Interim CFO
GILLIS JONATHAN
CAO and Interim CFO
Foff Erin Pennock
Chief Medical Officer
Foff Erin Pennock
Chief Medical Officer
Kroeger Christopher A.
Chief Executive Officer
Kroeger Christopher A.
Chief Executive Officer
Hanson Kristopher
General Counsel
Hanson Kristopher
General Counsel
Hanson Kristopher
General Counsel
Hanson Kristopher
General Counsel
Kroeger Christopher A.
Chief Executive Officer
Kroeger Christopher A.
Chief Executive Officer
Kroeger Christopher A.
Chief Executive Officer
Kroeger Christopher A.
Chief Executive Officer
Kroeger Christopher A.
Chief Executive Officer
Kroeger Christopher A.
Chief Executive Officer
Kroeger Christopher A.
Chief Executive Officer
Foff Erin Pennock
Chief Medical Officer
Foff Erin Pennock
Chief Medical Officer
Lillie James Woodruff
Chief Scientific Officer
Kroeger Christopher A.
Chief Executive Officer
Kroeger Christopher A.
Chief Executive Officer
Setia Vishwas
Chief Financial Officer
Setia Vishwas
Chief Financial Officer
Foff Erin Pennock
Chief Medical Officer
Foff Erin Pennock
Chief Medical Officer
Lillie James Woodruff
Chief Scientific Officer
Lillie James Woodruff
Chief Scientific Officer
Kroeger Christopher A.
Chief Executive Officer
Kroeger Christopher A.
Chief Executive Officer
Setia Vishwas
Chief Financial Officer
Setia Vishwas
Chief Financial Officer
Foff Erin Pennock
Chief Medical Officer
Foff Erin Pennock
Chief Medical Officer
Lillie James Woodruff
Chief Scientific Officer
Lillie James Woodruff
Chief Scientific Officer
Kroeger Christopher A.
Chief Executive Officer
Kroeger Christopher A.
Chief Executive Officer
Setia Vishwas
Chief Financial Officer
Setia Vishwas
Chief Financial Officer
Setia Vishwas
Chief Financial Officer
Setia Vishwas
Chief Financial Officer
Foff Erin Pennock
Chief Medical Officer
Foff Erin Pennock
Chief Medical Officer
Foff Erin Pennock
Chief Medical Officer
Foff Erin Pennock
Chief Medical Officer
Hanson Kristopher
General Counsel
Hanson Kristopher
General Counsel
Hanson Kristopher
General Counsel
Hanson Kristopher
General Counsel
Lillie James Woodruff
Chief Scientific Officer
Lillie James Woodruff
Chief Scientific Officer
Lillie James Woodruff
Chief Scientific Officer
Lillie James Woodruff
Chief Scientific Officer
Kroeger Christopher A.
Chief Executive Officer
Kroeger Christopher A.
Chief Executive Officer
Kroeger Christopher A.
Chief Executive Officer
Kroeger Christopher A.
Chief Executive Officer
GILLIS JONATHAN
CAAO and PAO
GILLIS JONATHAN
CAAO and PAO
Kreitzer Anatol
Chief Discovery Officer
Kreitzer Anatol
Chief Discovery Officer
Kreitzer Anatol
Chief Discovery Officer
GILLIS JONATHAN
CAAO and PAO
GILLIS JONATHAN
CAAO and PAO
GILLIS JONATHAN
CAAO and PAO
Malenka Robert C.
Director
Pavlov George
Director
Pavlov George
Director
Pavlov George
Director
Garnett Timothy John
Director
Catalyst4, Inc.
10% owner
Novo Holdings A/S
10% owner
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Sep 16, 2026 | Hanson Kristopher General Counsel | Sale | 16,509 | $11.67 | $192,660 | |
| Aug 14, 2026 | Catalyst4, Inc. 10% owner | Purchase | 4,400,000 | $11.38 | $50,072,000 | |
| Aug 14, 2026 | Catalyst4, Inc. 10% owner | Purchase | 2,928,686 | $11.38 | $33,328,154 | |
| Aug 03, 2026 | Lillie James Woodruff Chief Scientific Officer | Sale | 22,082 | $12.54 | $276,908 | |
| Jul 30, 2026 | Catalyst4, Inc. 10% owner | Purchase | 1,000,000 | $13.00 | $13,000,000 | |
| Jul 29, 2026 | Catalyst4, Inc. 10% owner | Purchase | 3,000 | $12.63 | $37,890 | |
| Jul 28, 2026 | Catalyst4, Inc. 10% owner | Purchase | 65,137 | $11.69 | $761,393 | |
| Jul 28, 2026 | Catalyst4, Inc. 10% owner | Purchase | 141,088 | $10.74 | $1,515,511 | |
| Jul 28, 2026 | Cox Troy Director | Purchase | 15,620 | $9.52 | $148,702 | |
| Jul 17, 2026 | Kreitzer Anatol Chief Discovery Officer | Sale | 200 | $38.39 | $7,678 | |
| Jul 17, 2026 | Kreitzer Anatol Chief Discovery Officer | Sale | 14,140 | $37.70 | $533,078 | |
| Jul 17, 2026 | Kreitzer Anatol Chief Discovery Officer | Sale | 2,833 | $37.05 | $104,963 | |
| Jul 17, 2026 | GILLIS JONATHAN CAO and Interim CFO | Sale | 900 | $38.17 | $34,353 | |
| Jul 17, 2026 | GILLIS JONATHAN CAO and Interim CFO | Sale | 16,969 | $37.61 | $638,204 | |
| Jul 17, 2026 | GILLIS JONATHAN CAO and Interim CFO | Sale | 600 | $36.51 | $21,906 | |
| Jul 15, 2026 | Foff Erin Pennock Chief Medical Officer | Sale | 7,845 | $37.04 | $290,579 | |
| Jul 15, 2026 | Foff Erin Pennock Chief Medical Officer | Sale | 7,155 | $36.16 | $258,725 | |
| May 18, 2026 | Kroeger Christopher A. Chief Executive Officer | Sale | 198 | $28.15 | $5,574 | |
| May 18, 2026 | Kroeger Christopher A. Chief Executive Officer | Sale | 118,037 | $27.19 | $3,209,426 | |
| May 11, 2026 | Hanson Kristopher General Counsel | Sale | 5,808 | $30.56 | $177,492 | |
| May 11, 2026 | Hanson Kristopher General Counsel | Sale | 6,979 | $30.04 | $209,649 | |
| May 11, 2026 | Hanson Kristopher General Counsel | Sale | 846 | $28.70 | $24,280 | |
| May 11, 2026 | Hanson Kristopher General Counsel | Sale | 284 | $27.61 | $7,841 | |
| May 11, 2026 | Kroeger Christopher A. Chief Executive Officer | Sale | 5,890 | $30.56 | $179,998 | |
| May 11, 2026 | Kroeger Christopher A. Chief Executive Officer | Sale | 6,871 | $30.04 | $206,405 | |
| May 11, 2026 | Kroeger Christopher A. Chief Executive Officer | Sale | 877 | $28.70 | $25,170 | |
| May 11, 2026 | Kroeger Christopher A. Chief Executive Officer | Sale | 342 | $27.57 | $9,429 | |
| May 08, 2026 | Kroeger Christopher A. Chief Executive Officer | Sale | 3,205 | $29.20 | $93,586 | |
| May 08, 2026 | Kroeger Christopher A. Chief Executive Officer | Sale | 1,582 | $28.56 | $45,182 | |
| May 08, 2026 | Kroeger Christopher A. Chief Executive Officer | Sale | 29,624 | $27.48 | $814,068 | |
| May 07, 2026 | Foff Erin Pennock Chief Medical Officer | Sale | 117 | $29.10 | $3,405 | |
| May 07, 2026 | Foff Erin Pennock Chief Medical Officer | Sale | 4,321 | $28.52 | $123,235 | |
| May 07, 2026 | Lillie James Woodruff Chief Scientific Officer | Sale | 721 | $28.28 | $20,390 | |
| May 07, 2026 | Kroeger Christopher A. Chief Executive Officer | Sale | 5,220 | $29.15 | $152,163 | |
| May 07, 2026 | Kroeger Christopher A. Chief Executive Officer | Sale | 14,880 | $28.47 | $423,634 | |
| May 06, 2026 | Setia Vishwas Chief Financial Officer | Sale | 2,068 | $29.07 | $60,117 | |
| May 06, 2026 | Setia Vishwas Chief Financial Officer | Sale | 8,496 | $28.04 | $238,228 | |
| May 06, 2026 | Foff Erin Pennock Chief Medical Officer | Sale | 15,900 | $29.13 | $463,167 | |
| May 06, 2026 | Foff Erin Pennock Chief Medical Officer | Sale | 8,152 | $28.04 | $228,582 | |
| May 06, 2026 | Lillie James Woodruff Chief Scientific Officer | Sale | 16,421 | $29.13 | $478,344 | |
| May 06, 2026 | Lillie James Woodruff Chief Scientific Officer | Sale | 8,390 | $28.04 | $235,256 | |
| May 06, 2026 | Kroeger Christopher A. Chief Executive Officer | Sale | 15,603 | $29.13 | $454,515 | |
| May 06, 2026 | Kroeger Christopher A. Chief Executive Officer | Sale | 8,098 | $28.04 | $227,068 | |
| May 05, 2026 | Setia Vishwas Chief Financial Officer | Sale | 968 | $29.00 | $28,072 | |
| May 05, 2026 | Setia Vishwas Chief Financial Officer | Sale | 9,935 | $28.12 | $279,372 | |
| May 05, 2026 | Foff Erin Pennock Chief Medical Officer | Sale | 931 | $29.00 | $26,999 | |
| May 05, 2026 | Foff Erin Pennock Chief Medical Officer | Sale | 9,645 | $28.12 | $271,217 | |
| May 05, 2026 | Lillie James Woodruff Chief Scientific Officer | Sale | 963 | $29.00 | $27,927 | |
| May 05, 2026 | Lillie James Woodruff Chief Scientific Officer | Sale | 10,132 | $28.12 | $284,912 | |
| May 05, 2026 | Kroeger Christopher A. Chief Executive Officer | Sale | 928 | $29.00 | $26,912 | |
| May 05, 2026 | Kroeger Christopher A. Chief Executive Officer | Sale | 9,544 | $28.12 | $268,377 | |
| May 04, 2026 | Setia Vishwas Chief Financial Officer | Sale | 787 | $30.12 | $23,704 | |
| May 04, 2026 | Setia Vishwas Chief Financial Officer | Sale | 325 | $29.56 | $9,607 | |
| May 04, 2026 | Setia Vishwas Chief Financial Officer | Sale | 8,989 | $28.28 | $254,209 | |
| May 04, 2026 | Setia Vishwas Chief Financial Officer | Sale | 4,803 | $27.36 | $131,410 | |
| May 04, 2026 | Foff Erin Pennock Chief Medical Officer | Sale | 700 | $30.08 | $21,056 | |
| May 04, 2026 | Foff Erin Pennock Chief Medical Officer | Sale | 312 | $29.56 | $9,223 | |
| May 04, 2026 | Foff Erin Pennock Chief Medical Officer | Sale | 5,460 | $28.37 | $154,900 | |
| May 04, 2026 | Foff Erin Pennock Chief Medical Officer | Sale | 9,180 | $27.50 | $252,450 | |
| May 04, 2026 | Hanson Kristopher General Counsel | Sale | 683 | $30.08 | $20,545 | |
| May 04, 2026 | Hanson Kristopher General Counsel | Sale | 296 | $29.56 | $8,750 | |
| May 04, 2026 | Hanson Kristopher General Counsel | Sale | 3,908 | $28.29 | $110,557 | |
| May 04, 2026 | Hanson Kristopher General Counsel | Sale | 9,030 | $27.50 | $248,325 | |
| May 04, 2026 | Lillie James Woodruff Chief Scientific Officer | Sale | 705 | $30.08 | $21,206 | |
| May 04, 2026 | Lillie James Woodruff Chief Scientific Officer | Sale | 320 | $29.56 | $9,459 | |
| May 04, 2026 | Lillie James Woodruff Chief Scientific Officer | Sale | 5,526 | $28.37 | $156,773 | |
| May 04, 2026 | Lillie James Woodruff Chief Scientific Officer | Sale | 9,250 | $27.50 | $254,375 | |
| May 04, 2026 | Kroeger Christopher A. Chief Executive Officer | Sale | 697 | $30.08 | $20,966 | |
| May 04, 2026 | Kroeger Christopher A. Chief Executive Officer | Sale | 311 | $29.56 | $9,193 | |
| May 04, 2026 | Kroeger Christopher A. Chief Executive Officer | Sale | 5,427 | $28.37 | $153,964 | |
| May 04, 2026 | Kroeger Christopher A. Chief Executive Officer | Sale | 9,136 | $27.50 | $251,240 | |
| Apr 28, 2026 | GILLIS JONATHAN CAAO and PAO | Sale | 700 | $30.83 | $21,581 | |
| Apr 28, 2026 | GILLIS JONATHAN CAAO and PAO | Sale | 17,235 | $30.33 | $522,738 | |
| Apr 27, 2026 | Kreitzer Anatol Chief Discovery Officer | Sale | 7,821 | $30.50 | $238,541 | |
| Apr 27, 2026 | Kreitzer Anatol Chief Discovery Officer | Sale | 29,255 | $29.63 | $866,826 | |
| Apr 27, 2026 | Kreitzer Anatol Chief Discovery Officer | Sale | 8,346 | $28.96 | $241,700 | |
| Apr 27, 2026 | GILLIS JONATHAN CAAO and PAO | Sale | 14,363 | $30.46 | $437,497 | |
| Apr 27, 2026 | GILLIS JONATHAN CAAO and PAO | Sale | 29,623 | $29.60 | $876,841 | |
| Apr 27, 2026 | GILLIS JONATHAN CAAO and PAO | Sale | 7,914 | $28.94 | $229,031 | |
| Apr 15, 2026 | Malenka Robert C. Director | Sale | 8,593 | $26.90 | $231,152 | |
| Feb 20, 2026 | Pavlov George Director | Purchase | 9,920 | $17.86 | $177,171 | |
| Feb 19, 2026 | Pavlov George Director | Purchase | 4,422 | $17.57 | $77,695 | |
| Feb 18, 2026 | Pavlov George Director | Purchase | 10,658 | $17.48 | $186,302 | |
| Feb 10, 2026 | Garnett Timothy John Director | Purchase | 14,124 | $17.89 | $252,678 | |
| Oct 28, 2025 | Catalyst4, Inc. 10% owner | Purchase | 5,441,176 | $17.00 | $92,499,992 | |
| Oct 28, 2025 | Novo Holdings A/S 10% owner | Purchase | 952,941 | $17.00 | $16,199,997 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.